RG tragedy: Aggressive protests only alternative now, feel junior doctors and victim’s father

Posted on by Vividh Bharathi

Kolkata, Dec 14 (IANS) Renewed and aggressive protests on the streets are the only alternative now to get justice for the Kolkata-based R.G. Kar Medical College & Hospital doctor who became the victim of a brutal rape and murder within the hospital premises in August this year, opined the junior doctors as well as parents of the victim on Saturday.

Their realisation comes in the wake of the failure of the Central Bureau of Investigation (CBI) in filing a charge sheet within 90 days against two individuals accused of tampering evidence in the rape and murder case, following which a special court in Kolkata, on Friday, granted “default bail” to former and controversial R.G. Kar principal Sandip Ghosh and former SHO of Tala Police Station Abhijit Mondal.

On Saturday, West Bengal Junior Doctors’ Front (WBJDF), the umbrella body spearheading the movement on this issue, brought out a protest rally to CBI’s special crime unit office at CGO complex Salt Lake on the northern outskirts of Kolkata, which was attended by the victim’s father.

“More aggressive protests on the streets are the only way left for us. We have to hit the streets again on a daily basis again as we had been doing before,” the victim’s father said. He said that he had been apprehensive of Ghosh and Mondal getting bail since he and his family were not happy with the progress of the investigation by the CBI.

The victim’s father also said that his family is also considering legal options on whether the decision of the lower court can be challenged at a higher court or not.

A leading face of the junior doctor’s movement on the issue Debasish Halder said he is happy that thousands of common people have joined them in the protest rally. “We are organising this protest to give a message to CBI that the legal system cannot be turned into a farcical exercise in such a manner. We want to send the message that the common people are with us and in the coming days we will be going for bigger protests,” he said.

Already WBJDF leadership has hinted that they might resume their cease-work protests which they withdrew keeping the larger public interest in mind.

–IANS

src/uk

Related Posts

Biotech startups in India surged from 50 to about 9,000 in last decade: Jitendra Singh

New Delhi, Dec 21 (IANS) From just 50 biotech startups in 2014 in India, the ecosystem has grown to nearly 9,000 in the last decade, said Union Minister Jitendra Singh.

At an event held in the national capital, Singh attributed the increase to the remarkable growth in bio-economy in the last 10 years — from $10 billion in 2014 to over $130 billion in 2024. The bio-economy industry is expected to reach $300 billion by 2030.

“With the kind of threat of pollution, the climate challenges, etc., being faced, this government has held sustainability at a very high priority. This is quite contrary to the times till about 10-15 years ago when India was not taken very seriously as far as issues like climate or the green concerns because they thought either India was alien to it or maybe we didn’t understand the seriousness of it,”

Singh noted that “sustainability” is of high priority for the government amid the continuing threat of “pollution, and the climate change challenges”.

He also highlighted India’s aim to achieve a net zero target by 2070, as Prime Minister Narendra Modi announced at COP-26 in 2021.

Singh informed that in the last few years, the government has undertaken several initiatives towards sustainability. This includes the Green Hydrogen mission, the mission for climate change, and the deep sea mission.

The government’s recently introduced ‘BioE3 Policy’ is also an important step forward towards sustainable growth in the backdrop of climate change, depleting non-renewable resources and unsustainable waste generation.

“The rise of biotech startups is pivotal for our future economy. These efforts place India at the forefront of the global bioplastics movement, showing the world how biotechnology can contribute to a cleaner, more sustainable future,” Singh said, in October.

–IANS

rvt/

Heart muscle can regenerate after failure in some people with artificial hearts: Study

New York, Dec 22 (IANS) Heart muscle can regenerate after failure in some people with artificial hearts, an international research team has found.

The team co-led by a physician-scientist at the University of Arizona College of Medicine – Tucson’s Sarver Heart Center in the US found that a subset of artificial heart patients can regenerate heart muscle, which may open the door to new ways to treat and perhaps someday cure heart failure.

There is no cure for heart failure, though medications can slow its progression. The only treatment for advanced heart failure, other than a transplant, is pump replacement through an artificial heart, called a left ventricular assist device, which can help the heart pump blood.

“Skeletal muscle has a significant ability to regenerate after injury. If you’re playing soccer and you tear a muscle, you need to rest it, and it heals,” said Hesham Sadek, chief of the Division of Cardiology at the University of Arizona College of Medicine – Tucson’s Department of Medicine.

“When a heart muscle is injured, it doesn’t grow back. We have nothing to reverse heart muscle loss,” Sadek said in a paper published in the journal Circulation.

Sadek led a collaboration between international experts to investigate whether heart muscles can regenerate.

The project began with tissue from artificial heart patients provided by colleagues at the University of Utah Health and School of Medicine led by Stavros Drakos, a pioneer in left ventricular assist device-mediated recovery.

The investigators found that patients with artificial hearts regenerated muscle cells at more than six times the rate of healthy hearts.

“This is the strongest evidence we have, so far, that human heart muscle cells can actually regenerate, which really is exciting, because it solidifies the notion that there is an intrinsic capacity of the human heart to regenerate,” Sadek said.

It also strongly supports the hypothesis that the inability of the heart muscle to ‘rest’ is a major driver of the heart’s lost ability to regenerate shortly after birth. It may be possible to target the molecular pathways involved in cell division to enhance the heart’s ability to regenerate, said the study authors.

–IANS

na/

Autism a significant health burden in India: Study

New Delhi, Dec 20 (IANS) Autism spectrum disorder (ASD) is a significant health burden in India, according to a study, published in The Lancet Psychiatry journal, on Friday.

Autism spectrum disorder is a neurological and developmental disorder. The condition majorly affects how people interact, communicate, and behave with others.

The study, based on the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021, ranks autism among the top 10 causes of non-fatal health burden in youth under 20 years old.

The study showed that India had 708·1 case of ASD per 100, 000 persons in 2021. Of these, 483·7 were females, while 921·4 were males. About 140 per 100,000 persons suffered poor health and disability due to ASD in India in 2021.

Globally, an estimated 61.8 million people, or one in every 127 persons were autistic in 2021. The study also showed stark disparities based on gender.

At 1,065 cases per 100,000 males, the global prevalence of ASD was found to be significantly higher among males. It was almost double the global prevalence among females (508 per 100,000 females), the study showed.

While the high-income Asia Pacific, including Japan, recorded the highest prevalence globally (1,560 per 100,000 people), Tropical Latin America and Bangladesh reported the lowest number of ASD cases.

“The findings underscore the urgent need for early detection and sustained support for autistic individuals and their caregivers worldwide,” said the researchers, while urging the need to prioritise resources for early detection of the disease.

The researchers also called for developing improved diagnostic tools, particularly for adults and those in low and middle-income countries with limited access to care, caregiver support, and services tailored to the evolving needs of autistic individuals across their lifespan.

Further, the team also highlighted the need to improve geographic data coverage and targeted interventions for comorbidities and mortality risks, such as suicide among people with ASD.

–IANS

rvt/